ZICHE, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 19.132
EU - Europa 13.753
AS - Asia 7.755
SA - Sud America 1.265
AF - Africa 261
Continente sconosciuto - Info sul continente non disponibili 235
OC - Oceania 22
Totale 42.423
Nazione #
US - Stati Uniti d'America 18.914
GB - Regno Unito 3.538
CN - Cina 2.761
SG - Singapore 2.322
RU - Federazione Russa 2.179
IE - Irlanda 1.776
IT - Italia 1.675
UA - Ucraina 1.243
BR - Brasile 1.071
SE - Svezia 1.039
VN - Vietnam 856
FR - Francia 816
DE - Germania 718
HK - Hong Kong 605
KR - Corea 419
FI - Finlandia 403
IN - India 248
CA - Canada 108
BD - Bangladesh 101
TR - Turchia 99
ZA - Sudafrica 78
AR - Argentina 76
ES - Italia 69
IQ - Iraq 58
MX - Messico 56
NG - Nigeria 55
NL - Olanda 52
PL - Polonia 46
BE - Belgio 44
ID - Indonesia 35
JP - Giappone 34
CI - Costa d'Avorio 32
EC - Ecuador 30
PK - Pakistan 30
AT - Austria 25
MA - Marocco 25
SA - Arabia Saudita 23
CO - Colombia 20
KE - Kenya 20
NP - Nepal 19
UZ - Uzbekistan 19
VE - Venezuela 19
AU - Australia 18
CL - Cile 18
DZ - Algeria 17
LT - Lituania 15
PH - Filippine 15
BG - Bulgaria 13
IL - Israele 13
JO - Giordania 13
CZ - Repubblica Ceca 12
PY - Paraguay 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
EG - Egitto 9
JM - Giamaica 9
PT - Portogallo 9
AZ - Azerbaigian 8
BY - Bielorussia 8
PE - Perù 8
GR - Grecia 7
GT - Guatemala 7
KG - Kirghizistan 7
MY - Malesia 7
TT - Trinidad e Tobago 7
AL - Albania 6
AM - Armenia 6
DK - Danimarca 6
EE - Estonia 6
EU - Europa 6
HU - Ungheria 6
OM - Oman 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
IR - Iran 5
SN - Senegal 5
TN - Tunisia 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
KH - Cambogia 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AO - Angola 3
CH - Svizzera 3
CY - Cipro 3
HR - Croazia 3
LB - Libano 3
MM - Myanmar 3
MN - Mongolia 3
SY - Repubblica araba siriana 3
DM - Dominica 2
GE - Georgia 2
Totale 42.163
Città #
Southend 3.222
Fairfield 1.983
Dallas 1.904
Dublin 1.759
Ashburn 1.551
Singapore 1.383
Chandler 1.068
Jacksonville 1.009
Woodbridge 941
Houston 895
Seattle 803
Wilmington 782
Cambridge 679
San Jose 675
Santa Clara 597
Moscow 585
Hong Kong 577
Milan 557
Beijing 543
Ann Arbor 464
Council Bluffs 458
Hefei 454
Seoul 417
Princeton 363
The Dalles 338
Nanjing 312
Ho Chi Minh City 236
Los Angeles 227
Rome 216
Siena 206
Hanoi 190
Lauterbourg 186
Boardman 162
San Diego 152
Helsinki 150
Menlo Park 148
New York 133
Nanchang 126
Columbus 118
San Mateo 115
Dong Ket 108
Buffalo 105
Fremont 101
Pune 85
Tianjin 85
São Paulo 79
Shenyang 74
Munich 73
Kunming 67
Izmir 63
Johannesburg 57
Bengaluru 55
Florence 54
Hebei 52
London 52
Redondo Beach 52
Abuja 51
Figino 51
Orem 50
Da Nang 46
Changsha 45
Chicago 45
Brussels 44
Shanghai 43
Turku 43
Atlanta 42
Warsaw 41
Jinan 40
San Francisco 40
Dearborn 38
Zhengzhou 38
Toronto 37
Málaga 36
Brooklyn 35
Norwalk 35
Abidjan 32
Chennai 31
Frankfurt am Main 31
Düsseldorf 30
Haiphong 30
Jiaxing 30
Lancaster 30
Falls Church 29
Hangzhou 29
Amsterdam 28
Tokyo 28
Turin 28
Boston 27
Nuremberg 27
Phoenix 27
Redwood City 27
Guangzhou 26
Belo Horizonte 23
Naples 23
Rio de Janeiro 23
Stockholm 23
Mexico City 22
Poplar 22
Denver 19
Jakarta 19
Totale 29.310
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 443
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 427
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 404
A fucose-containing O-glycoepitope on bovine and human nucleolin 390
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 356
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 340
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 315
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 305
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 304
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 303
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 301
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 300
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 299
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 298
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 284
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 280
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 280
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 276
Divergent effects of quercetin conjugates on angiogenesis 274
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 273
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 273
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 272
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 264
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 262
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 260
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 259
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 257
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 255
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 254
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 252
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 248
Biological characterization of nanocomposite hydrogels 247
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 247
Analysis of the role of chemokines in angiogenesis 246
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 246
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 244
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 243
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 241
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 237
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium 237
Activity of "NO-donor" or "NO-mediated" drugs 235
Studying vascular angiogenesis and senescence in zebrafish embryos 235
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 230
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 230
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 230
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 230
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 223
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 222
Absence of PAF actions increases angiogenesis 222
Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1α expression in an AhR-independent fashion 222
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 222
Role of nitric oxide in the modulation of angiogenesis 219
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 219
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 219
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 219
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 217
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through a5b1 integrin 217
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 217
Activation of MAPK in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats 216
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 215
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 215
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 214
Assessing vascular senescence in zebrafish 213
Differential contribution of bradykinin receptors in angiogenesis 212
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 211
Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. 210
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 209
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 208
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 208
Angiogenesis 206
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells 205
Nitric oxide in tumor angiogenesis 204
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 204
The rabbit corneal pocket assay 204
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 204
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 203
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 203
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 200
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 200
Role of prostaglandin E1 and copper in angiogenesis 199
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 197
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 196
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 195
New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis 195
The corneal pocket assay 195
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 194
Molecular mechanisms of resistance to anti-angiogenic drugs 193
N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and supresses neuroblastoma tumor growth 192
In vitro and in vivo models to study chemokine regulation of angiogenesis 189
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. 188
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 186
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 186
Nitric oxide and angiogenesis 185
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 185
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses 185
Repurposing of drugs for triple negative breast cancer: an overview 185
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 184
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto chick chorioallantoic membrane: endothelial fenestration and angiogenesis 183
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 182
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth 182
Totale 23.864
Categoria #
all - tutte 131.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.651 0 392 153 349 122 120 133 122 105 327 245 583
2022/20233.805 248 272 497 589 387 778 51 288 406 69 125 95
2023/20242.371 115 50 155 187 62 696 835 56 3 26 16 170
2024/20254.812 88 292 407 301 452 193 95 298 347 216 606 1.517
2025/202612.521 1.022 1.804 1.417 1.218 2.255 478 1.632 299 460 582 245 1.109
2026/20271.110 567 543 0 0 0 0 0 0 0 0 0 0
Totale 42.423